Clinical Trials Directory

Trials / Completed

CompletedNCT00825578

Use of Endobronchial Valves in Non-Upper Lobe Heterogeneous Emphysema

Comparative Study of Bronchoscopic Lung Volume Reduction to Evaluate Relative Efficacy in Patients With Non-Upper Lobe Emphysema

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Royal Brompton & Harefield NHS Foundation Trust · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Hypothesis: Patients with advanced emphysema with predominance of the disease in areas other than the upper lobes, as determined by high resolution computed tomography (HRCT), could have a positive response to valve treatment.

Conditions

Interventions

TypeNameDescription
DEVICEIntra-bronchial valve (Spiration IBV)Device: Intra-bronchial valve (Spiration IBV) The IBV is comprised of a Nitnol frame and a polymer membrane, which is held against the airway mucosa by six elastic struts and will expand and contract with airway movement during breathing. The valve is designed to conform to the size and shape of the airways. The frame has 5 flexible anchors that gently secure to the mucosal wall at a controlled depth. Valves are available in 5, 6 and 7mm diameters appropriate for different airways. During a minimally invasive procedure, a catheter is passed through a bronchoscope (a flexible tube passed into the airways through the mouth) to deploy the umbrella-shaped valves into the airways. Only flexible bronchoscopy equipment is required. The valves are designed to be removed if indicated.

Timeline

Start date
2009-01-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2009-01-21
Last updated
2012-02-06

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00825578. Inclusion in this directory is not an endorsement.